ESC 365 - Does earlier treatment impact CV outcomes?

Open Access

Does earlier treatment impact CV outcomes?

Session: LDL Management in ACS: Lower is better but is Earlier better?

Topic: Prevention

Speaker: Professor M. Sabatine (Boston, US)

Sponsored by Amgen (Europe) GmbH

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Marc Sabatine

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

25 presentations

1 follower

4 more presentations in this session

LDL Management in ACS: Lower is better but is Earlier better? - Sponsored by Amgen (Europe) GmbH

Striking while the plaque is hot: emerging evidence.

Speaker: Associate Professor T. Leucker (Baltimore, US) Professor S. Nicholls (Melbourne, AU)

What is the relevance to everyday practice?

Speaker: Professor G. Montalescot (Paris, FR)

Live Panel discussion and close.

Access the full session

LDL Management in ACS: Lower is better but is Earlier better?

Speakers: Professor M. Sabatine, Associate Professor T. Leucker, Professor S. Nicholls, Professor G. Montalescot

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources